CYCN - CIK 0001755237
Cyclerion Therapeutics, Inc. (CYCN) reported revenue of $2.07M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $2.07M | +3.7% |
| FY 2024 | $2.00M | - |
| FY 2023 | $0.00 | -100.0% |
| FY 2022 | $297.00K | -92.5% |
| FY 2021 | $3.94M | +71.7% |
| FY 2020 | $2.30M | -49.1% |
| FY 2019 | $4.51M | - |
Cyclerion Therapeutics, Inc. (CYCN) reported revenue of $2.07M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Cyclerion Therapeutics, Inc.'s revenue declined from $4.51M to $2.07M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.